ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences

Rhea-AI Summary

ANI Pharmaceuticals, Inc. (ANIP) announced that its CEO and CFO will participate in two upcoming healthcare conferences in New York City. The first event is Capital One 1st Annual Biotech/Biopharma Disruptors on May 14, 2024, and the second is H.C. Wainwright 2nd Annual BioConnect Conference at NASDAQ on May 20, 2024. Investors can schedule 1x1 meetings with management via provided contacts. The webcast of the events will be available on ANIP's website for 90 days.

BAUDETTE, Minn., May 01, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will participate at two upcoming healthcare conferences in New York City as follows:

Capital One 1st Annual Biotech/Biopharma Disruptors Event
Date:	Tuesday, May 14, 2024
Time:	12:15pm ET
To schedule a 1x1 meeting with management, please contact kristen.patrick@capitalone.com
H.C. Wainwright 2nd Annual BioConnect Conference at NASDAQ
Date:	Monday, May 20, 2024
Time:	9:00am ET
Webcast:	Click Here
To schedule a 1x1 meeting with management, please contact meetings@hcwco.com.

The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.

About ANI

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset Purified Cortrophin^® Gel, strengthening its Generics business with enhanced research and development capabilities, leveraging its U.S. based manufacturing footprint, and delivering innovation in Established Brands. For more information, please visit our website www.anipharmaceuticals.com.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.

T: 212-452-2793
E: lwilson@insitecony.com

Source: ANI Pharmaceuticals, Inc.

FAQ

When will ANI Pharmaceuticals participate in healthcare conferences in New York City?

ANI Pharmaceuticals will participate in two upcoming healthcare conferences in New York City. The Capital One 1st Annual Biotech/Biopharma Disruptors event is on May 14, 2024, and the H.C. Wainwright 2nd Annual BioConnect Conference at NASDAQ is on May 20, 2024.

Who will represent ANI Pharmaceuticals at the healthcare conferences in New York City?

Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will represent ANI Pharmaceuticals at the upcoming healthcare conferences in New York City.

How can investors schedule a meeting with ANI Pharmaceuticals management during the conferences?

Investors can schedule 1x1 meetings with ANI Pharmaceuticals management by contacting kristen.patrick@capitalone.com for the Capital One event and meetings@hcwco.com for the H.C. Wainwright event.

Where can I access the webcast of the healthcare conferences?

The live and archived webcast of the healthcare conferences will be accessible on ANI Pharmaceuticals' website at www.anipharmaceuticals.com under the Investors section and Events and Presentations. The webcast will be available for 90 days.